gadobutrol injection
fresenius kabi usa, llc - gadobutrol (unii: 1bj477io2l) (gadolinium cation (3+) - unii:azv954tz9n) - gadobutrol injection is indicated for use with magnetic resonance imaging (mri) in adult and pediatric patients, including term neonates to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system. gadobutrol injection is indicated for use with mri in adult patients to assess the presence and extent of malignant breast disease. gadobutrol injection is indicated for use in magnetic resonance angiography (mra) in adult and pediatric patients, including term neonates, to evaluate known or suspected supra-aortic or renal artery disease. gadobutrol injection is indicated for use in cardiac mri (cmri) to assess myocardial perfusion (stress, rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (cad). gadobutrol injection is contraindicated in patients with history of severe hypersensitivity reactions to gadobutrol injection. gbcas cross the placenta and result in fetal exposure and gadolinium retention.
gadobutrol injection
slate run pharmaceuticals, llc - gadobutrol (unii: 1bj477io2l) (gadolinium cation (3+) - unii:azv954tz9n) - gadobutrol injection is indicated for use with magnetic resonance imaging (mri) in adult and pediatric patients, including term neonates to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system. gadobutrol injection is indicated for use with mri in adult patients to assess the presence and extent of malignant breast disease. gadobutrol injection is indicated for use in magnetic resonance angiography (mra) in adult and pediatric patients, including term neonates, to evaluate known or suspected supra-aortic or renal artery disease. gadobutrol injection is indicated for use in cardiac mri (cmri) to assess myocardial perfusion (stress, rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (cad). gadobutrol injection is contraindicated in patients with history of severe hypersensitivity reactions to gadobutrol injection. gbcas cross the placenta and result in fetal exposure and gadolinium retention.
gadobutrol injection
fresenius kabi usa, llc - gadobutrol (unii: 1bj477io2l) (gadolinium cation (3+) - unii:azv954tz9n) - gadobutrol injection is indicated for use with magnetic resonance imaging (mri) in adult and pediatric patients, including term neonates, to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system. gadobutrol injection is indicated for use with mri in adult patients to assess the presence and extent of malignant breast disease. gadobutrol injection is indicated for use in magnetic resonance angiography (mra) in adult and pediatric patients, including term neonates, to evaluate known or suspected supra-aortic or renal artery disease. gadobutrol injection is indicated for use in cardiac mri (cmri) to assess myocardial perfusion (stress, rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (cad). gadobutrol injection is contraindicated in patients with history of severe hypersensitivity reactions to gadobutrol. risk summary gbcas cross the placenta and result in fetal exposure and gadolinium retenti
gadobutrol injection
slate run pharmaceuticals, llc - gadobutrol (unii: 1bj477io2l) (gadolinium cation (3+) - unii:azv954tz9n) - gadobutrol injection is indicated for use with magnetic resonance imaging (mri) in adult and pediatric patients, including term neonates to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system. gadobutrol injection is indicated for use with mri in adult patients to assess the presence and extent of malignant breast disease. gadobutrol injection is indicated for use in magnetic resonance angiography (mra) in adult and pediatric patients, including term neonates, to evaluate known or suspected supra-aortic or renal artery disease. gadobutrol injection is indicated for use in cardiac mri (cmri) to assess myocardial perfusion (stress, rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (cad). gadobutrol injection is contraindicated in patients with history of severe hypersensitivity reactions to gadobutrol injection. gbcas cross the placenta and result in fetal exposure and gadolinium retention.
gadovist 1.0 mmol/ml solución inyectable intravenosa
bayer ag - gadobutrol (equivalente a 1 mmol de gadobutrol) - gadobutrol (equivalente a 1 mmol de gadobutrol)....604.720 mg
gadovist solution for injection 1.0mmol/mml
bayer plc - gadobutrol - solution for injection - gadobutrol 1 mmol/ml - contrast media
gadovist (in prefilled syringe/cartridge) solution for injection 1.0mmol/ml
bayer plc - gadobutrol - solution for injection in a pre-filled syringe - gadobutrol 1.0 mmol/ml - contrast media
gadograf 1.0 mmol/ml solution for injection - 7.5ml vial
bayer public limited company - gadobutrol - solution for injection - gadobutrol 1 millimole(s)/millilitre - contrast media
gadograf 1.0 mmol/ml solution for injection - 15ml vial
bayer public limited company - gadobutrol - solution for injection - gadobutrol 1 millimole(s)/millilitre - contrast media
gadograf 1.0 mmol/ml solution for injection - 65ml bottle
bayer public limited company - gadobutrol - solution for injection - gadobutrol 1 millimole(s)/millilitre - contrast media